Table 3.
Group characteristics of propensity-matched cohorts.
| Total (n = 28) | Non-ECMO (n = 14) | Pro-ECMO (n = 14) | P -value | |
|---|---|---|---|---|
| Age, year | 63 (58–65) | 62 (56–64) | 64 (62–67) | 0.210 |
| Gender, male/female | 22/6 | 11/3 | 11/3 | 1.000 |
| BMI (kg/m2) | 20.7 ± 2.9 | 20.2 ± 2.7 | 21.1 ± 3.1 | 0.635 |
| Diagnosis, n (%) | ||||
| IPF | 13 (46.4) | 6 (42.9) | 7 (50.0) | 0.120 |
| COPD | 6 (21.4) | 3 (21.4) | 3 (21.4) | |
| Bronchiectasis | 3 (10.7) | 3 (21.4) | 0 (0) | |
| Re-transplant | 2 (7.1) | 0 (0) | 2 (14.3) | |
| Pneumosilicosis | 3 (10.7) | 2 (14.3) | 1 (7.1) | |
| IPAH or PVOD | 1 (3.6) | 0 (0) | 1 (7.1) | |
| Type of LTx, n (%) | ||||
| Single-LTx | 11 (39.3) | 6 (42.9) | 5 (35.7) | 0.699 |
| Bilateral-LTx | 17 (60.7) | 8 (57.1) | 9 (64.3) | |
| 30-day survival, n (%) | 26 (92.9) | 13 (92.9) | 13 (92.9) | 1.000 |
| 90-day survival, n (%) | 25 (89.3) | 12 (85.7) | 13 (92.9) | 1.000 |
BMI, body mass index; IPF, idiopathic pulmonary fibrosis; COPD, chronic obstructive pulmonary disease; IPAH, idiopathic pulmonary arterial hypertension; PVOD, peripheral vascular occlusive disease; LTx, lung transplantation.